Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€107.55

€107.55

-2.400%
-2.65
-2.400%
€180.00
 
11:51 / Tradegate WKN: 659990 / Symbol: MKGAF / Name: Merck / Stock / Pharmaceuticals / Large Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
JavaScript chart by amCharts 3.21.15
JavaScript chart by amCharts 3.21.15
JavaScript chart by amCharts 3.21.15JS chart by amCharts
Select a timeframe to show chart data
From: to:
Zoom:
Loading data...
Your prediction

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
The full analysis of the stock Merck KGaA is only available for our menbers.
Not a member yet? Sign up for free!

Financial data and news for Merck

sharewise wants to provide you with the best news and tools for Merck, so we directly link to the best financial data sources.

News

Merck Stock: Pharma Giant Completes $3 Billion Acquisition
Merck Stock: Pharma Giant Completes $3 Billion Acquisition

Darmstadt-based pharmaceutical company Merck has finalized its acquisition of US cancer specialist SpringWorks Therapeutics for $47 per share in cash, representing a total value of approximately $3

Merck Stock: Solid Q1 Overshadowed by Lowered Outlook
Merck Stock: Solid Q1 Overshadowed by Lowered Outlook

Merck KGaA delivered impressive first-quarter results for 2025, with net profit climbing 5.5% to €738 million and earnings per share reaching €1.69, representing a 5.6% increase compared to the same

3 Robotics Stocks That Could Benefit From U.S. Manufacturing Boom
3 Robotics Stocks That Could Benefit From U.S. Manufacturing Boom

With the latest round of tariffs from the Trump administration in early April 2025, investors and business owners alike are reckoning with the idea that the policy is encouraging a repatriation of

Institutional Investors Bet $1B on These 4 Stocks—Should You?
Institutional Investors Bet $1B on These 4 Stocks—Should You?

Institutional investing is a key measure that retail investors can use to gauge market sentiment on an individual stock or asset. Hedge funds, advisors and other institutional investors employ

Merck Stock: Technical Stabilization Emerges After Slump
Merck Stock: Technical Stabilization Emerges After Slump

Darmstadt-based pharmaceutical and technology company Merck is showing initial signs of technical stabilization following an extended period of weakness. Currently trading at approximately €135, the

Merck: 4 No-Brainer Reasons to Buy This Dip
Merck: 4 No-Brainer Reasons to Buy This Dip

Big pharma has come under a lot of scrutiny from regulators and consumers as sentiment sours on the industry. As such, the market can be unforgiving when companies even slightly miss

Why Merck Stock Slipped Today: https://g.foolcdn.com/editorial/images/827114/two-people-in-white-lab-coats-looking-at-a-computer-display.jpg
Why Merck Stock Slipped Today

On Tuesday, Merck (NYSE: MRK) wasn't one of the better-performing pharmaceutical stocks. In contrast to certain peers, the company's share price declined following the release of second-quarter

Merck Posts Q2 EPS Beat Revenue Slips
Merck Posts Q2 EPS Beat Revenue Slips

Merck (NYSE:MRK), a leading developer of prescription medicines, vaccines, and animal health products, released its second-quarter 2025 results on July 29, 2025. The most notable news was a beat on

Got $1,000? 3 High-Yield Healthcare Stocks to Buy and Hold Forever: https://g.foolcdn.com/editorial/images/826516/22_08_22-a-hand-planting-money-in-the-ground-to-show-long-term-investing-growth-_mf-dload.jpg
Got $1,000? 3 High-Yield Healthcare Stocks to Buy and Hold Forever

Healthcare stocks aren't exactly known for offering large yields, with the average healthcare stock at just 1.8% or so. You can do better than that and get reliable dividend stocks while you are at

Does This Move Make Merck Stock a Buy?: https://g.foolcdn.com/editorial/images/824791/physician-giving-medicine-to-elderly-patient.jpg
Does This Move Make Merck Stock a Buy?

Merck (NYSE: MRK), a leading pharmaceutical company, generates consistent revenue and profits. However, the stock has been under pressure over the past year due to its reliance on Keytruda, its

Merck Just Announced a $10 Billion Deal That Will Help Diversify Its Business: https://g.foolcdn.com/editorial/images/824726/a-group-of-business-people-talking-outside.jpg
Merck Just Announced a $10 Billion Deal That Will Help Diversify Its Business

One of the biggest concerns with healthcare giant Merck (NYSE: MRK) is its dependence on top-selling cancer drug Keytruda. While it has been a beast for the business over the years, generating

2 Top Stocks Down 16% and 17% This Year to Buy and Hold: https://g.foolcdn.com/editorial/images/823999/pharmacist-talking-to-patient.jpg
2 Top Stocks Down 16% and 17% This Year to Buy and Hold

Most people love a bargain; investors do too. Purchasing shares of companies that can perform well over long periods is already pretty exciting, but it's even more so when they can be scooped up

2 Dividend Stocks to Buy and Never Sell: https://g.foolcdn.com/editorial/images/821703/research-scientists-drugs-pharma-biotech.jpg
2 Dividend Stocks to Buy and Never Sell

There are excellent reasons to invest in dividend stocks, including the fact that they typically outperform their non-dividend-paying peers in delivering strong market returns over long periods.

2 Beaten-Down Stocks That Are Great Buys on the Dip: https://g.foolcdn.com/editorial/images/817207/online-shopping-small-business-etsy-e-commerce.jpg
2 Beaten-Down Stocks That Are Great Buys on the Dip

Even when equities are volatile, investors can find great stocks to buy. And the rules for investing in the current environment aren't that different, at least for those focused on the long game

Stock Market Crash: 3 High-Yielding Dividend Stocks Near Their 52-Week Lows to Buy Right Now
Stock Market Crash: 3 High-Yielding Dividend Stocks Near Their 52-Week Lows to Buy Right Now

One great thing about a crash or downturn in the markets is that it can allow you to go bargain hunting fairly easily. Many stocks have been falling this year, and if you're a dividend investor, you

EQS-Adhoc: Merck KGaA: Merck confirms late-stage discussions with SpringWorks Therapeutics, Inc. on potential acquisition
EQS-Adhoc: Merck KGaA: Merck confirms late-stage discussions with SpringWorks Therapeutics, Inc. on potential acquisition
EQS-Adhoc: Merck KGaA: Merck confirms late-stage discussions with SpringWorks Therapeutics, Inc. on potential acquisition
Should You Buy the 3 Highest-Paying Dividend Stocks in the Dow Jones?
Should You Buy the 3 Highest-Paying Dividend Stocks in the Dow Jones?

The Dow Jones Industrial Average (DJINDICES: ^DJI) fell sharply after the U.S. released a new tariff program. Does that open up some opportunities for investors who like high-yield stocks? A quick

2 Beaten-Down Stocks to Buy and Hold for a Decade
2 Beaten-Down Stocks to Buy and Hold for a Decade

Recent market volatility notwithstanding, equities generally deliver solid returns over long periods, like a decade. The key is to purchase shares of robust companies, occasionally adding more, and

Is Merck Stock a Bargain Buy?
Is Merck Stock a Bargain Buy?

Merck (NYSE: MRK) is a top healthcare company with one of the best drugs ever made in its portfolio: Keytruda. While there are concerns about its patent losses in the future, its sales are still

2 Beaten-Down Stocks to Buy on the Dip
2 Beaten-Down Stocks to Buy on the Dip

While the recent market dip has created bargains, some stocks have sufficiently lagged the market in the past year to warrant that title regardless of what's transpired in 2025. Among them are

Is Merck Stock a Buy?
Is Merck Stock a Buy?

It's been a rough start to 2025 for Merck (NYSE: MRK) shareholders following a less-than-stellar fourth-quarter earnings report. Even as the pharmaceutical giant exceeded Wall Street estimates with

Want Decades of Passive Income? 2 Stocks to Buy Now and Hold Forever.
Want Decades of Passive Income? 2 Stocks to Buy Now and Hold Forever.

Most companies don't survive for decades, much less pay regular dividends for that long. However, some rare corporations can pull it off. These are the kinds of stocks long-term investors will often

EQS-Adhoc: Merck KGaA: Merck KGaA confirms discussions with Springworks Therapeutics, Inc. on potential acquisition
EQS-Adhoc: Merck KGaA: Merck KGaA confirms discussions with Springworks Therapeutics, Inc. on potential acquisition
EQS-Adhoc: Merck KGaA: Merck KGaA confirms discussions with Springworks Therapeutics, Inc. on potential acquisition
Better High-Yield Dividend Stock: Pfizer vs. Merck
Better High-Yield Dividend Stock: Pfizer vs. Merck

Investors looking for ways to pump up their passive income streams might want to turn their heads toward the pharmaceutical industry. At recent prices, you can buy shares of Merck (NYSE: MRK) that

Merck (MRK) Q4 2024 Earnings Call Transcript
Merck (MRK) Q4 2024 Earnings Call Transcript

Image source: The Motley Fool.

Merck (NYSE: MRK)Q4 2024 Earnings CallFeb 04, 2025, 9:00 a.m. ET

Operator

Continue reading

Source Fool.com